Fig. 4From: A randomized, clinical trial to assess the relative efficacy and tolerability of two doses of etoricoxib versus naproxen in patients with ankylosing spondylitisAverage Change From Week 6 Over Weeks 10 and 12 (Part II) in Spinal Pain Intensity (0–100 mm VAS)Back to article page